Cellectar Biosciences, Inc. — Director's Dealing 2017

Sep 25, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2017-09-18

Reporting Person: Longcor Jarrod (Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-18	Employee Stock Option (right to buy)	$1.83	A	25000	Acquired	2027-09-18	Common Stock (25000)	Direct

Footnotes

F1: Option vests in equal quarterly increments over a period of three years from the date of grant.